Thursday, July 7, 2016

FDA puts Juno's drug trial on hold after two patients die

July 7 (Reuters) - Drug developer Juno Therapeutics Inc

said U.S. health regulators were putting a mid-stage

study testing its lead drug on hold after two patients died last

week.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)